MEI Pharma Alpha and Beta Analysis
| MEIPDelisted Stock | USD 3.07 0.18 6.23% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as MEI Pharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in MEI Pharma over a specified time horizon. Remember, high MEI Pharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to MEI Pharma's market risk premium analysis include:
Beta 0.11 | Alpha 0.86 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
MEI |
MEI Pharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. MEI Pharma market risk premium is the additional return an investor will receive from holding MEI Pharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in MEI Pharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate MEI Pharma's performance over market.| α | 0.86 | β | 0.11 |
MEI Pharma Fundamentals Vs Peers
Comparing MEI Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze MEI Pharma's direct or indirect competition across all of the common fundamentals between MEI Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as MEI Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of MEI Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing MEI Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare MEI Pharma to competition |
| Fundamentals | MEI Pharma | Peer Average |
| Return On Equity | -0.9 | -0.31 |
| Return On Asset | -0.23 | -0.14 |
| Current Valuation | 59.84 M | 16.62 B |
| Shares Outstanding | 32.84 M | 571.82 M |
| Shares Owned By Insiders | 7.60 % | 10.09 % |
| Shares Owned By Institutions | 8.12 % | 39.21 % |
| Number Of Shares Shorted | 2.46 M | 4.71 M |
MEI Pharma Opportunities
MEI Pharma Return and Market Media
The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | MEIP Surges with 100 Million Litecoin Treasury Strategy | 07/18/2025 |
2 | Here Are Major Milestones for Litecoin So Far in 2025 | 07/25/2025 |
3 | Acquisition by Riezman Joshua of 10000 shares of MEI Pharma at 5.19 subject to Rule 16b-3 | 08/08/2025 |
4 | Can MEI Pharma Inc. deliver alpha - July 2025 Review High Win Rate Trade Alerts - thegnnews.com | 08/15/2025 |
5 | Litecoin Price Action Remains Flat as Investors Seek Faster-Growing Assets | 08/21/2025 |
6 | MEI Pharma Rating Increased to Hold at Wall Street Zen | 08/25/2025 |
7 | Crypto hoarding brings a stock pop for small firmsand in some cases shows patterns of possible insider trading | 08/28/2025 |
8 | Amdax Raises 23M for Bitcoin Treasury Europes Bold Bid to Rival MicroStrategy | 08/29/2025 |
About MEI Pharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including MEI or other delisted stocks. Alpha measures the amount that position in MEI Pharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
MEI Pharma Upcoming Company Events
As portrayed in its financial statements, the presentation of MEI Pharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MEI Pharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of MEI Pharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of MEI Pharma. Please utilize our Beneish M Score to check the likelihood of MEI Pharma's management manipulating its earnings.
| 8th of February 2024 Upcoming Quarterly Report | View | |
| 9th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 24th of September 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 30th of June 2023 Last Financial Announcement | View |
Build Portfolio with MEI Pharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in MEI Stock
If you are still planning to invest in MEI Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MEI Pharma's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |